Wegovy - Pill (Novo Nordisks Oral GLP-1) Described as the first oral GLP-1 medicine for obesity in the US, the Wegovy pill was granted FDA approval in December 2025
When stored properly in the refrigerator at 2 to 8 degrees Celsius, compounded tirzepatide can remain stable for the duration of its BUD
Deeply cleanses pores and removes excess sebum and blackheads
Aqua (Water), Niacinamide, Dipropylene Glycol, Squalane, Arbutin, Parfum (Fragrance), Cetyl Ethylhexanoate, Polyglyceryl3 Methylglucose Distearate, Lactobacillus/Soybean Ferment Extract, Glutathione, Hydroxyacetophenone, Sodium Citrate, PEG60 Hydrogenated Castor Oil, Butylene Glycol, Hydroxyethylcellulose, Sodium Polyacrylate, Adenosine, Hydrogenated Polydecene, Disodium EDTA, Centella Asiatica Extract, Trideceth6, Propolis Extract, Madecassoside, Asiatic Acid, Madecassic Acid, Asiaticoside, Ethylhexylglycerin, Kojic Acid Dipalmitate
Inform patients that leaving hydrocodone bitartrate and acetaminophen tablets unsecured can pose a deadly risk to others in the home (see WARNINGS, DRUG ABUSE AND DEPENDENCE)
Scan this QR code (or ask your GP to) with smartphone camera to read the digital version of this article, complete with clickable scientific references and interactive resource links Imprint and Publication Details Published by: PhysioPod UK Ltd, Daybrook Nottingham, Nottinghamshire, NG5 6AS United Kingdom Contact Information: Telephone: +44 (0)115 916 7685 Email: [email protected] Website: www.physiopod.co.uk Company Registration: Co
